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Abstract
The mevalonate-based isoprenoid biosynthetic pathway is responsible for producing cholesterol in humans and is used
commercially to produce drugs, chemicals, and fuels. Heterologous expression of this pathway in Escherichia coli has
enabled high-level production of the antimalarial drug artemisinin and the proposed biofuel bisabolane. Understanding the
kinetics of the enzymes in the biosynthetic pathway is critical to optimize the pathway for high flux. We have characterized
the kinetic parameters of phosphomevalonate kinase (PMK, EC 2.7.4.2) from Saccharomyces cerevisiae, a previously
unstudied enzyme. An E. coli codon-optimized version of the S. cerevisiae gene was cloned into pET-52b+, then the C-
terminal 6X His-tagged protein was expressed in E. coli BL21(DE3) and purified on a Ni2+ column. The KM of the ATP binding
site was determined to be 98.3 mM at 30uC, the optimal growth temperature for S. cerevisiae, and 74.3 mM at 37uC, the
optimal growth temperature for E. coli. The KM of the mevalonate-5-phosphate binding site was determined to be 885 mM
at 30uC and 880 mM at 37uC. The Vmax was determined to be 4.51 mmol/min/mg enzyme at 30uC and 5.33 mmol/min/mg
enzyme at 37uC. PMK is Mg2+ dependent, with maximal activity achieved at concentrations of 10 mM or greater. Maximum
activity was observed at pH= 7.2. PMK was not found to be substrate inhibited, nor feedback inhibited by FPP at
concentrations up to 10 mM FPP.
Citation: Garcia DE, Keasling JD (2014) Kinetics of Phosphomevalonate Kinase from Saccharomyces cerevisiae. PLoS ONE 9(1): e87112. doi:10.1371/
journal.pone.0087112
Editor: Shekhar C. Mande, National Centre for Cell Science, India
Received March 1, 2013; Accepted December 21, 2013; Published January 27, 2014
Copyright:  2014 Garcia, Keasling. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Joint BioEnergy Institute (JBEI), which is funded by the U.S. Department of Energy, Office of Science, Office of Biological
and Environmental Research, under contract number DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: keasling@berkeley.edu
Introduction
The mevalonate pathway is an important conduit for the
production of crucial metabolites with a wide array of functions,
including terpenoids [1,2], hormones and steroids [3]. The
heterologous expression of this pathway in Escherichia coli has
enabled high-level production of the antimalarial drug artemisinin
[4–6], but the chemical structures of these metabolites also make
them interesting targets for solving some of the most crucial
problems in the energy market [7,8]. With only slight modifica-
tions to mevalonate pathway intermediates and products, either in
vivo or through traditional chemical engineering processes post cell
culture extraction, these molecules can be transformed into
biofuels that, depending on our ability to scale-up, could offset
or replace traditional liquid fuels [9]. This would allow us to
replace petroleum-based, CO2 producing fuels with fuels that are
carbon neutral. Although industrial-scale corn-based ethanol
production is already a reality in the energy market, ethanol is a
less than desirable biofuel because not only does it divert crops
from the food supply, it is not compatible with our current
distribution infrastructure or vehicle fleet [10].
Whether these fuel alternatives are five-carbon alcohols derived
from the mevalonate pathway intermediates isopentenyl pyro-
phosphate and dimethylallyl pyrophosphate [11], or downstream,
terpene-based molecules like bisabolene [8], further improvement
of titers may be realized through a more robust understanding of
the enzymes in the mevalonate pathway and the ways in which
those enzymes are regulated by metabolic intermediates. In
particular, proteomics data has previously shown that the fourth
and fifth enzymes in the pathway—mevalonate kinase (MK) and
phosphomevalonate kinase (PMK), respectively—are expressed at
relatively low levels and may be targets for increasing overall
isoprenoid production [12,13]. Previous work has also shown that
substrate inhibition and feedback inhibition of MK may be
responsible for limiting flux through the pathway [14]. Because
MK—a phosphotransferase that acts on mevalonate and ATP to
yield mevalonate-5-phosphate—and PMK—a phosphotransferase
that acts on mevalonate-5-phosphate and ATP to yield mevalo-
nate-5-diphosphate—both require ATP to function and down-
stream prenyl phosphates might act as general ATP binding site
inhibitors, PMK was identified as another potential source of
pathway regulation.
PMKs from other sources have been studied revealing
implications for pathway engineering. For example, PMK from
E. faecalis is Mn2+ dependent rather than Mg2+ dependent [15].
Pig-derived PMK is substrate inhibited by ATP under high ATP,
low mevalonate phosphate concentrations [16]. If S. cerevisiae PMK
is similarly dependent or inhibited it would make an ideal target
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for protein engineering. Furthermore, S. cerevisiae prefers to grow at
30uC, but much of our production takes place in E. coli, which
necessitates understanding how PMK activity is affected by a
change in growth temperature from 30uC to 37uC. Herein we
report cloning a codon-optimized sequence of S. cerevisiae PMK
into an expression vector, the expression and purification of PMK
in E. coli, and the kinetic characterization of the purified enzyme.
Results and Discussion
Although phosphomevalonate kinase (PMK) from S. cerevisiae
has previously been studied in partially purified lysates [17], and
even utilized to study the kinetics of another enzyme [18], this is
the first time PMK from S. cerevisiae has been kinetically
characterized in isolation. In a study of the partially purified
enzyme it was reported that pH did not affect PMK activity, but
we found that PMK does have an optimal activity at pH=7.2, and
its activity drops off below pH=6.5 and above pH=8.0 (Figure 1).
Although at first glance there is an apparent ‘‘shoulder’’ in the pH
profile, careful consideration of the profile shows that the shoulder
is within error and therefore cannot be considered to conclusively
exist. Although we did not test a wide array of storage conditions,
solutions with high PMK concentrations were found to be stable
long term only at pH=8.0 with 800 mM NaCl. As found
previously S. cerevisiae PMK shows a cation dependence on Mg2+,
with 10 mM corresponding to maximal activity (Figure 2).
Kinetic constants were determined by nonlinear regression
analysis using the solver function in Microsoft Excel. The KM for
ATP, KM
ATP, was determined to be 98.3 mM and 74.3 mM at
30uC and 37uC, respectively. The KM for mevalonate-5-
phosphate, KM
mev-p, was determined to be 885 mM and 880 mM
at 30uC and 37uC, respectively (Figure 3). Vmax was determined to
be 4.51 mmol/min/mg enzyme and 5.33 mmol/min/mg enzyme at
30uC and 37uC, respectively (Figure 4). In contrast, the KM
ATP,
KM
mev-p, and Vmax for the Enterococcus faecalis PMK, which is Mn
dependent, were reported to be 170 mM, 190 mM, and 3.9 mmol/
min/mg enzyme [15]. The values for the Streptococcus pneumonia
PMK were reported to be 74 mM, 4.2 mM, and 5.5 mmol/min/mg
enzyme [19]. The values for pig liver PMK have been reported to
be 43 mM, 12 mM, and 51 mmol/min/mg enzyme [16]. For the
recombinant human PMK, the values were reported to be
107 mM, 34 mM, and 46 mmol/min/mg enzyme [20]. The high
KM
mev-p for the S. cerevisiae PMK makes it less ideal than enzymes
with a low KM, as it would only reach its maximal rate at a high
concentration of mevalonate-5-phosphate. Because of the Mn
dependence of the E. faecalis PMK, it may not function fully if
expressed in E. coli or other organisms. In contrast, the S.
pneumonia, pig, and human PMKs have reasonable values for
KM
ATP and KM
mev-p, making them better choices for a
heterologous pathway. In terms of maximum rates, the mamma-
lian enzymes are high than the microbial enzymes.
Because the S. cerevisiae PMK has been used heterologously in E.
coli for production of isoprenoids [4–8,11], the temperature effect
on PMK activity is important, particularly at E. coli’s optimal
growth temperature of 37uC. Despite expectations that PMK
activity might diminish with increasing the temperature from the
preferred 30uC growth temperature of S. cerevisiae to the 37uC
preferred by E. coli, PMK activity was shown to slightly increase
with the increase in temperature. This increased activity bodes
well for the production of isoprenoid products, including advanced
biofuels, via the mevalonate pathway if the low protein expression
levels currently observed can be increased [12,13]_ENREF_9. It
should be noted that although we were able to achieve very high
yields of PMK using pET-52b+ for the purpose of isolating and
purifying the enzyme, increasing PMK expression in production
strains by using high copy plasmids would be counterproductive to
increasing overall biofuels production as doing so would divert an
unnecessary amount of resources into the production of protein to
the detriment of fuel titers.
One regulatory mechanism for controlling PMK activity we can
rule out is feedback inhibition, as the presence of farnesyl
Figure 1. pH dependence of S. cerevisiae phosphomevalonate kinase.
doi:10.1371/journal.pone.0087112.g001
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pyrophosphate (FPP)—a known inhibitor of MK [18]—did not
affect PMK activity at concentrations up to 10 mM FPP (data not
shown). Of the publications reporting the kinetics of PMKs from
various organisms, none have reported inhibition by prenyl
phosphates. Furthermore, unlike S. cerevisiae mevalonate kinase
[18], PMK did not demonstrate substrate inhibition. The lack of
feedback and substrate inhibition in the S. cerevisiae PMK is an
attractive feature for increasing production of a desired isoprenoid.
Nevertheless, S. pneumonia PMK, which has a high Vmax and low
KMs, is a much better enzyme and should be incorporated into
future production strains. An additional advantage of the S.
pneumonia PMK is that its crystal structure of the has been solved
Figure 2. Divalent cation dependence. Closed circles are data for Mg2+ and open circles are data for Mn2+.
doi:10.1371/journal.pone.0087112.g002
Figure 3. Initial reaction velocity as a function of ATP concentration. Closed circles are data for incubation at 37uC and open circles are data
for incubation at 30uC.
doi:10.1371/journal.pone.0087112.g003
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[21] and the kinetic mechanism of its catalysis has been described
in detail [19].
With the addition of PMK from this study, the S. cerevisiae-
derived mevalonate pathway enzymes that have been kinetically
characterized include hydroxymethylglutaryl synthase [22], hy-
droxymethylglutaryl reductase [14], mevalonate kinase [18],
phosphomevalonate decarboxylase [23], and farnesyl pyrophos-
phate synthase [24], leaving acetyl-CoA C-acetyltransferase and
isopentenyl diphosphate isomerase uncharacterized. Although
isopentenyl diphosphate isomerase has been isolated and studied
[25], the difficulty associated with detecting the isomerization of a
single bond is likely why the kinetic constants have yet to be
determined. In combination with traditional genetic engineering
techniques, such as varying promoter strength, and newly
developed technologies for varying expression, such as RBS
calculators [26], studying the kinetics of these remaining enzymes
should allow isoprenoid production from engineered microbes to
be optimized more rationally.
Materials and Methods
Codon Optimization of PMK
The original S. cerevisiae PMK sequence (accession number
NM_001182727), which was downloaded from the BioCyc.org
database, was codon optimized by DNA2.0 (Menlo Park, CA) for
expression in E. coli. Codon optimization replaced codons rare for
E. coli with more frequently used codons. The sequences of the
original and codon-optimized versions of the genes are presented
in Figure S1.
Expression Plasmid Construction
A chemically-competent strain of E. coli DH10B was trans-
formed with pET-52b+ (Novagen, Germany) and then used to
prepare the plasmid according to the instructions and materials in
a Qiagen (Valencia, California) Spin Miniprep Kit. The codon-
optimized PMK sequence was PCR amplified with primers that
added a BsaI restriction site with an NcoI overhang on the 59 end
of the sequence and a SacI restriction site on the 39 end of the
sequence, then digested with the appropriate restriction enzymes
(all enzymes from New England BioLabs, Ipswich, Massachusetts),
and cloned into pET-52b+ to make expression plasmid pET-52b+
_coPMK-His. Confirmation of expression plasmid construction
was accomplished by sequencing the cloning region using T7
primers (sequencing and primers from Quintara Biosciences,
Albany, California).
PMK-His Expression and Purification
Ideal conditions for PMK expression were screened on
NuPAGE 10% Bis-Tris SDS-PAGE gels and the supplies
indicated in the accompanying protocol (Invitrogen, Grand Island,
New York) from 5-mL cultures that spanned a range of media
types, growth temperatures, inducer concentrations, and growth
times. Protein expression was ultimately accomplished by growing
a 2-L culture in Terrific Broth (Invitrogen) to OD600 = 0.6 at
37uC, inducing with 100 mM IPTG (Sigma Aldrich, St. Louis,
Missouri), then growing at 18uC for approximately two days (until
stationary phase was reached). Cells were pelleted in 250-mL
portions, flash frozen in liquid nitrogen after medium removal,
and then stored at 280uC prior to further processing. On ice, cells
from one 250-mL portion were suspended in 25 mL of a lysis
buffer (10 mM Imidizole, 300 mM NaCl, 50 mM NaH2PO4,
pH=8.0; Sigma Aldrich), sonicated for 10 minutes in a water bath
to break up residual clumps, then homogenized with two passes
through an EmulsiFlexH-C3 (Avestin, Canada). Cell debris was
removed by centrifugation at 12,000 X g for 30 minutes. Cleared
lysate was bound to 2-mL of Ni-NTA resin (Qiagen) at 4uC by
rocking gently for 30 minutes. The resin was then bedded in a
column, washed with 20 column volumes (CV) of buffer
containing 20 mM imidizole, then the protein was eluted with
10 CV of buffer containing 500 mM imidizole. Buffer exchange
Figure 4. Initial reaction velocity as a function of mevalonate-5-phosphate concentration. Closed circles are data for incubation at 37uC
and open circles are data for incubation at 30uC.
doi:10.1371/journal.pone.0087112.g004
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into 20 mM Tris, 50 mM NaCl, pH=7.0 was accomplished on an
AKTA (GE Healthcare Life Sciences, Pittsburgh, Pennsylvania)
using a GE Healthcare HiPrep 26/10 Desalting Column (17-
5087-01). Protein was then concentrated using VivaSpin 20 3,000-
MWCO filters (Sartorius, Bohemia, New York). Protein concen-
tration was determined using a Nanodrop (Thermo Scientific,
West Palm Beach, Florida). The protein was then diluted so that
glycerol (Sigma) was 50% v/v and stored at 220uC.
Activity Assay
All chemicals and supporting enzymes were purchased from
Sigma-Aldrich. Reaction progress was monitored spectrophotomet-
rically at 339 nm for NADH consumption on a 96-well plate in a
Spectramax M2 (Molecular Devices, Sunnyvale, California). 100-mL
enzymatic assay mixtures contained 200 mM Tris (pH=7.2),
100 mM KCl, 10 mM MgCl2, 0.81 mM NADH, 1.5 mM phos-
phoenolpyruvate, 0.682U pyruvate kinase, 0.990 U lactate dehydro-
genase, 0.1 mg PMK, 0.1–8.0 mM ATP, and 0.2–10.0 mM
mevalonate-5-phosphate. Stock concentrations of NADH and pH
neutralized ATP were confirmed through their extinction coefficients
(ATPe259 nm=15.4 mM
21 cm21, NADHe339 nm=6.22 mM
21 cm21).
All conditions were repeated twelve times for statistical analysis, from
which KM (mM) and reaction velocities (mM mev-PP formed*mi-
nute21 * mg PMK21) were calculated. When studying pH effect and
divalent cation dependence, ATP and mevalonate-5-phosphate were
held constant and data were normalized to the maximum observed
reaction velocities. To ensure PMK was the rate-limiting enzyme,
when necessary the following standard controls and results were
verified: doubling the PMK added doubled the observed rate,
doubling the supporting enzymes added did not affect the observed
rate, and doubling the phosphoenolpyruvate concentration did not
affect the observed rate.
Supporting Information
Figure S1 Sequences of the original PMK and the codon-
optimized version of PMK.
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